<DOC>
	<DOC>NCT01721408</DOC>
	<brief_summary>This is a comparative study of the efficacy and safety of tigecycline to imipenem/cilastatin in hospitalized patients with a complicated intra-abdominal infection.</brief_summary>
	<brief_title>A Study To Determine The Efficacy And Safety Of Tigecycline Compared With Imipenem/Cliastatin to Treat Complicated Intra-Abdominal Infection</brief_title>
	<detailed_description />
	<mesh_term>Infection</mesh_term>
	<mesh_term>Communicable Diseases</mesh_term>
	<mesh_term>Intraabdominal Infections</mesh_term>
	<mesh_term>Imipenem</mesh_term>
	<mesh_term>Tigecycline</mesh_term>
	<mesh_term>Minocycline</mesh_term>
	<mesh_term>Cilastatin</mesh_term>
	<criteria>Hospitalized male or female subjects, at least 18 year of age. Complicated intraabdominal infection is present at most under two weeks duration. Minimal clinical criteria at the time of intraabdominal infection diagnosis or highly suspected intraabdominal infection. Anticipated length of antibiotic therapy less than 5 days or the likelihood that the subject will not complete the course of treatment. Intraabdominal infection known to be caused by 1 or more bacterial pathogens not susceptible to both of the study drugs. Had accepted nonstudy antibiotics more than 24 hr within 72 hrs before enrollment except for subjects declared prior failures.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2016</verification_date>
</DOC>